Peter K. Harris
Peter K. Harris has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
- Aadel A. Chaudhuri
Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
63 shared publications - Jose P. Zevallos
Department of Otolaryngology, University of Pittsburgh Medical Center , Pittsburgh, PA
47 shared publications - Noah Earland
Division of Cancer Biology, Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
47 shared publications - Ricardo J. Ramirez
Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri
47 shared publications - Sophie P. Gerndt
Division of Otolaryngology-Head and Neck Surgery, Allegheny Health Network, Pittsburgh, Pennsylvania
47 shared publications - Damion Whitfield
Droplet Biosciences, Inc., Cambridge, Massachusetts
45 shared publications
Latest Publications
- Open Access
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 - 2 of 3 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Co-mutation plot from targeted sequencing of 73 HPV- HNSCC patient tumors
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 - 2 of 3 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Co-mutation plot from targeted sequencing of 73 HPV- HNSCC patient tumors
- Open Access
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 - 1 of 2 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Co-mutation plot from targeted sequencing of 73 HPV- HNSCC patient lymph samples
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 - 1 of 2 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Co-mutation plot from targeted sequencing of 73 HPV- HNSCC patient lymph samples
- Open Access
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 - 1 of 2 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Orthogonal Validation of Lymph and Plasma MRD Detection.
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 - 1 of 2 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Orthogonal Validation of Lymph and Plasma MRD Detection.
- Open Access
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 - 2 of 2 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Orthogonal Validation of Lymph and Plasma MRD Detection.
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 - 2 of 2 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Orthogonal Validation of Lymph and Plasma MRD Detection.
- Open Access
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 - 2 of 3 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Lymph ctDNA outperforms pathology biomarkers.
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 - 2 of 3 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Lymph ctDNA outperforms pathology biomarkers.
- Open Access
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 - 3 of 3 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Supplementary Figure 2 shows frequency/patterns of observed tumor mutations in patient tumors
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 - 3 of 3 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Supplementary Figure 2 shows frequency/patterns of observed tumor mutations in patient tumors
- Open Access
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 - 1 of 3 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Lymph ctDNA outperforms pathology biomarkers.
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 - 1 of 3 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Lymph ctDNA outperforms pathology biomarkers.
- Open Access
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
STables 1-9 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
STables 1-9: STable 1: H&N Panel regions. STable 2: Covariate analysis of cohort. STables 3 & 4: COX regression analysis. STables 5-7: Cohort Characteristics. STable 8: Lymph sequencing metrics. STable 9: Tumor mutations by patient.
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSTables 1-9 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
STables 1-9: STable 1: H&N Panel regions. STable 2: Covariate analysis of cohort. STables 3 & 4: COX regression analysis. STables 5-7: Cohort Characteristics. STable 8: Lymph sequencing metrics. STable 9: Tumor mutations by patient.
- Open Access
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 - 2 of 2 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Co-mutation plot from targeted sequencing of 73 HPV- HNSCC patient lymph samples
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 - 2 of 2 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Co-mutation plot from targeted sequencing of 73 HPV- HNSCC patient lymph samples
- Open Access
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 - 1 of 3 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Co-mutation plot from targeted sequencing of 73 HPV- HNSCC patient tumors
- 6 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 - 1 of 3 from Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer
Co-mutation plot from targeted sequencing of 73 HPV- HNSCC patient tumors